Safety of in vivo adenovirus-mediated thymidine kinase treatment of oral cancer

Archives of Otolaryngology - Head and Neck Surgery

Volumn 123, Issue 12, 1997, Pages 1298-1302

  Sewell, Duane A ^a   Li, Daqing ^a   Duan, Ling ^a   Westra, William H ^a   O'Malley Jr , Bert W ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYMIDINE KINASE; VIRUS DNA; VIRUS ENZYME; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; GENE THERAPY; HERPES SIMPLEX VIRUS; MOUSE; MOUTH CANCER; NONHUMAN; SAFETY; VIRUS GENE;

EID: 0031441280     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.1997.01900120048007     Document Type: Article

References (13)

1. O'Malley BW Jr, Chen S-H, Schwartz MR, et al. Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res. 1995;55:1080-1085.
2. O'Malley BW Jr, Cope KA, Chen S-H, et al. Combination gene therapy for oral cancer in a murine model. Cancer Res. 1996;56:1737-1741.
3. O'Malley BW Jr, Cope KA, Johnson CS, Schwartz MR. A new immunocompetent murine model for oral cancer. Arch Otolaryngol Head Neck Surg. 1997;123: 20-24.
4. Clayman GL, El-Naggar AK, Roth JA, et al. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous cell carcinoma. Cancer Res. 1995;55:1-6.
5. Crystal RG, McElvaney NG, Rosenfeld MA, et al. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet. 1994;8:42-51.
6. Knowles MR, Hohneker KW, Zhou Z, et al. A controlled study of adenoviral vector mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med. 1995;333:823-831.
7. Yei S, Mittereder N, Wert S, et al. In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung. Hum Gene Ther. 1994;5:731-744.
8. Physicians' Desk Reference. Montvale, NJ: Medical Economics Co; 1996:2103-2110.
9. Matthews T, Boehme R. Antiviral activity and mechanism of action of ganciclovir. Rev Infect Dis. 1988;10:S490-S494.
10. Keay S, Bissett J, Merigan TC. Ganciclovir treatment of cytomegalovirus infection in iatrogenically immunocompromised patients. J Infect Dis. 1987;156: 1016.
11. Chen S-H, Shine D, Goodman JC, et al. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vitro. Proc Natl Acad Sci U S A. 1994;91:3054-3057.
12. Graham F, Prevec L. Methods in Molecular Biology: Gene Transfer and Expression Protocols. Totowa, NJ: Humana Press Inc; 1991;7.
13. Sewell DA, Li D, Duan L, Scwartz MR, O'Malley BW Jr. Optimizing 'suicide gene' therapy for head and neck cancer. Laryngoscope. 1997;107:1490-1495.